| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT04855552 Telehealth Weight Loss Program for Breast Cancer Survivors |
date change Primary completion pushed: 2026-07 -> 2027-07-31 |
| 2026-08-15 | NCT04855552 Telehealth Weight Loss Program for Breast Cancer Survivors |
date change Completion pushed: 2026-12 -> 2027-12-31 |
| 2026-08-15 | NCT05852860 A Patient-Oriented Research Mentoring Program in Tobacco Dependence and Implementation… |
overall status: Active, Not Recruiting → Enrolling by Invitation |
| 2026-08-14 | NCT05733715 Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma |
date change Primary completion pushed: 2026-06 -> 2028-04 |
| 2026-08-14 | NCT05733715 Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma |
date change Completion pushed: 2028-01 -> 2028-12 |
| 2026-08-13 | NCT03680677 Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With… |
date change Primary completion pushed: 2026-06-22 -> 2027-09-30 |
| 2026-08-13 | NCT03680677 Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With… |
date change Completion pushed: 2026-11 -> 2027-11 |
| 2026-08-13 | NCT05338307 Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer… |
date change Primary completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-08-13 | NCT05338307 Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer… |
date change Completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-08-13 | NCT06995703 Increasing Screening for Cancer Using EHR-Nudges Replication |
Trial completed |
| 2026-08-07 | NCT06870617 Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative… |
date change Primary completion pushed: 2026-07-01 -> 2026-10-01 |
| 2026-08-07 | NCT05086497 WBSI Guided Personalized Delivery of TTFields |
date change Primary completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-08-07 | NCT05086497 WBSI Guided Personalized Delivery of TTFields |
date change Completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-08-06 | NCT04827862 RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab +… |
Trial completed |
| 2026-08-06 | NCT04827862 RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab +… |
date change Primary completion moved earlier: 2026-12-01 -> 2026-05-01 |
| 2026-08-06 | NCT04827862 RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab +… |
date change Completion moved earlier: 2027-01 -> 2026-08-03 |
| 2026-07-23 | NCT05832008 Increasing Adherence to Lung Cancer Screening |
Trial completed |
| 2026-07-23 | NCT05832008 Increasing Adherence to Lung Cancer Screening |
date change Completion moved earlier: 2026-06-01 -> 2026-02-28 |
| 2026-07-23 | NCT03729518 TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck |
Trial completed |
| 2026-07-23 | NCT03729518 TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck |
date change Primary completion moved earlier: 2026-12 -> 2026-07-15 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-20 | NCT07715188 Low Dose Radiotherapy for Osteoarthritis | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07133074 | Allergy Delabeling in Antibiotic Stewardship - Intervention | Beta Lactam Allergy | Recruiting |
| Phase 2 | |||
| NCT03646617 | Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With… | Metastatic Melanoma | Recruiting |
| NCT06747845 | Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic… | Pancreatic Adenocarcinoma Metastatic | Recruiting |
| NCT07082439 | Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma | Colorectal Adenocarcinoma Metastatic in the Liver | Recruiting |
| NCT05932680 | Limited-duration Teclistamab | Myeloma Multiple | Recruiting |
| NCT06591819 | Hypofractionated WPPT With HDR Boost | Prostate Cancer | Recruiting |
| NCT05496036 | Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma | Merkel Cell Carcinoma | Recruiting |
| NCT04841148 | Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast… | Breast Cancer | Recruiting |
| NCT04523857 | ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in… | Breast Cancer | Recruiting |
| NCT04889716 | CAR-T Followed by Bispecific Antibodies | Large B-cell Lymphoma | Recruiting |
| NCT06458439 | Epcoritamab-CAR T Cells for Large B-cell Lymphomas | Lymphoma, Non-Hodgkin | Recruiting |
| NCT04339036 | CapTemY90 for Grade 2/3 NET Liver Metastases | Neuroendocrine Tumor Grade 2 | Recruiting |
| NCT05916196 | [18F]FES PET/.CT in Uterine Cancer | Uterine Cancer | Recruiting |
| NCT04332367 | Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or… | Non-small Cell Lung Cancer | Recruiting |
| NCT05758688 | PROton Therapy for Post Surgical Treatment of GYNecologic Cancer | Cervical Cancer | Recruiting |
| NCT03757689 | Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma | Melanoma | Active, Not Recruiting |
| NCT05297903 | XmAb20717 in Advanced Biliary Tract Cancers | Biliary Tract Cancer | Active, Not Recruiting |
| NCT04013854 | Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab | Melanoma Stage III | Active, Not Recruiting |
| NCT02153229 | Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant… | Epitheliod Malignant Pleural Mesothelioma | Active, Not Recruiting |
| NCT04221503 | Niraparib/TTFields in GBM | Glioblastoma | Active, Not Recruiting |
| NCT05318027 | ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy | Lung Cancer | Active, Not Recruiting |
| NCT05714657 | Shortened Course Adjuvant Radiotherapy Following TORS | HPV-Associated Oropharyngeal Squamous Cell Carcinoma | Active, Not Recruiting |
| NCT07059611 | Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma | Gastric Adenocarcinoma | Not Yet Recruiting |
| NCT03032406 | CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the… | Breast Cancer Stage IIB | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT04691817 | Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell… | Lung Cancer, Nonsmall Cell | Recruiting |